The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
VAXCYTE INC | COM | 92243G108 | 25,975,102 | 693,039 | SH | DFND | 1 | 0 | 693,039 | 0 | |
INOZYME PHARMA INC | COM | 45790W108 | 18,413,848 | 3,213,586 | SH | DFND | 1 | 0 | 3,213,586 | 0 | |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 142,043,933 | 782,008 | SH | DFND | 1 | 0 | 782,008 | 0 | |
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 6,259,451 | 569,041 | SH | DFND | 1 | 0 | 569,041 | 0 | |
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 649,570 | 743,215 | SH | DFND | 1 | 0 | 743,215 | 0 | |
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 5,884,902 | 1,560,982 | SH | DFND | 1 | 0 | 1,560,982 | 0 | |
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 2,629,139 | 1,891,467 | SH | DFND | 1 | 0 | 1,891,467 | 0 | |
RALLYBIO CORP | COM | 75120L100 | 13,730,517 | 2,404,644 | SH | DFND | 1 | 0 | 2,404,644 | 0 | |
EXSCIENTIA PLC | ADS | 30223G102 | 4,093,111 | 772,285 | SH | DFND | 1 | 0 | 772,285 | 0 | |
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 5,488,225 | 560,595 | SH | DFND | 1 | 0 | 560,595 | 0 | |
OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | 17,692,286 | 2,381,196 | SH | DFND | 1 | 0 | 2,381,196 | 0 |